AZTA logo

AZENTA INC

AZTANASDAQ
πŸ† #2174 by market capEarnings Nov 19 Β· PostUS Equity
$34.25β–² $0.00 (+0.00%)
After hours Β· at close
πŸ””
Track AZTA
Get earnings, price moves & breaking news on Telegram
Track
24hβ–² 0.0%
7dβ–Ό 0.1%
14dβ–² 3.6%
30dβ–² 3.8%
ytdβ–² 3.1%
1yβ–² 21.5%
🏦Market Cap
$1.58B
Small Cap
πŸ“ˆRevenue Growth (YoY)
+3.5%
Slowing
πŸ“ŠGross Margin
44.0%
Healthy
πŸ’΅FCF Margin
1.6%
Thin
βš–οΈP/S Ratio
2.6x
Cheap
Otter Score
80
Good

Trading Snapshot

Day Range
$33.83 – $34.59
52-Week Range
$15.93 – $41.73
Volume
$5.04B
Avg Volume
$4.38B
Shares Outstanding
46.1M
Next Earnings
Nov 8, 2026

Fundamentals Snapshot

Annual Revenue
$594M
Last Q Revenue
$161M
P/E Ratio
-12.4
P/S Ratio
2.6x
EPS (TTM)
$-2.71
Dividend Yield
0.00%
Dilution (1yr)
+0.7%

Why Investors Own AZTA

  • βœ“High-growth profile β€” revenue up +19.0% YoY with expanding US Equity exposure.
  • βœ“Healthy economics β€” 44% gross margin and 15% free-cash-flow margin.
  • βœ“New products and segments could unlock additional revenue streams.
⚠️ Key Risks

Execution delays, intensifying competition, and valuation compression if growth decelerates.

AZTA logo

AZENTA INC

AZTA
Financial Trends
RevenueThe total money the company brought in from sales, before subtracting any costs.
$594Mβ–² +3.6% YoY
Gross MarginOf every $1 of sales, how much is left after the direct cost of making the product/service. Higher = more efficient.
45.5%β–² +2.5% YoY
Operating IncomeProfit from the core business after operating costs, but before interest and taxes. Negative means the core business isn’t profitable yet.
βˆ’$11Mβ–Ό βˆ’62.4% YoY
Free Cash FlowCash left over after running the business and paying for equipment/capex. Negative means the company is burning cash.
$38Mβ–² +210.3% YoY
Shares OutstandingHow many shares exist. Rising means the company is issuing more shares, which dilutes (shrinks) each existing owner’s slice.
45.9Mβ–² +0.7% YoY
Net CashCash minus total debt. Positive = more cash than debt (financially strong); negative = more debt than cash (net debt).
$230Mβ–Ό βˆ’$93M YoY
StockOtter Β· stockotter.space

About AZENTA INC

Azenta, Inc. is a global leader specializing in advanced solutions for the discovery, handling, and preservation of life science samples. The company's operations span across North America, Europe, Asia Pacific (including China), and other international markets. Its business is structured into two main reportable segments: Life Sciences Products and Life Sciences Services. The Life Sciences Products division supplies sophisticated automated systems for the cold storage of chemical compounds and biological specimens. This segment also provides crucial equipment for sample preparation and manipulation, along with various consumables and specialized instruments that empower customers to effectively manage samples throughout their entire research and development workflows. Conversely, the Life Sciences Services segment offers a comprehensive suite of programs for sample management, integrated cold chain logistics, cutting-edge informatics, and a range of sample-centric laboratory services. These offerings are vital for propelling scientific research and accelerating drug development. Key services include secure sample banking, advanced genomic sequencing, gene synthesis, laboratory processing, detailed laboratory analysis, biospecimen acquisition, and other essential support functions. Azenta caters to a diverse client base within the life sciences sector, encompassing pharmaceutical companies, biotechnology firms, biorepositories, and academic or private research institutions. Established in 1978, the company, originally known as Brooks Automation, Inc., officially became Azenta, Inc. in December 2021. Its corporate headquarters are located in Chelmsford, Massachusetts.

🦦

Otter Score Breakdown

How it's scoredFive components, each rated 1–5β˜… and equally weighted (20%), averaged to a 0–100 score:πŸ’Ž Quality β€” gross marginπŸš€ Growth β€” revenue YoYβš–οΈ Valuation β€” P/S ratio⚑ Momentum β€” 30-day price changeπŸ’§ Dilution β€” 1-yr share issuance (buybacks score higher)
πŸ’ŽQualityβ˜…β˜…β˜…β˜…β˜…
πŸš€Growthβ˜…β˜…β˜…β˜…β˜…
βš–οΈValuationβ˜…β˜…β˜…β˜…β˜…
⚑Momentumβ˜…β˜…β˜…β˜…β˜…
πŸ’§Dilutionβ˜…β˜…β˜…β˜…β˜…
Overall Score
Good
80/100

Analyst Price Target

β“˜
Average Target
$42.53
β–² +24.2% Upside
High Target$48.39
Low Target$32.03
Based on 19 analysts

Latest News & Updates